New York, NY -- (SBWIRE) -- 10/01/2013 -- Three hot medical and tech stocks today
Penny Stock Investor Relations Network provides investors with the top penny stock news every trading day, throughout the day. With our alerts, you will know who to buy, who to sell and how to make a profit.
Today, three stocks that are poised to do well are Sigma Labs (OTCMKTS:SGLB), Decision Diagnostic Corp. (OTCBB:DECN) and Soligenx Inc. (OTCBB:SNGX)
Sigma Labs (OTCMKTS:SGLB) continues to move upwards, thanks in no small part to the positive news of a new research grant. On Friday it nearly went over the 12-cent level and selling exceeded $1.02 million on the news of the research grant.
Today, the shares are continuing to move upwards on the news that Sigma Labs is working on speeding up the 3D printing process. Today, the stock is staying around the 10 cents line.
With the company expected to become a trendsetter in the industry and there have been rumours of a buy-out by a larger company in the industry but nothing firm has appeared to back up these claims.
Will be a good bet to purchase early on before prices begin to move sky-high.
Decision Diagnostic Corp. (OTCBB:DECN) is a producer of generic glucose-test strips that is hoping to compete with the big boys. In September alone, shares shot from 20 cents to 80 cents and is now remaining steady at that mark.
Also on the medical technology side is Soligenx Inc. (OTCBB:SNGX), which is a pharmaceutical developer that recently lost some of its market value, sliding by 30 cents from $2.40 to $2.10 after three solid days of selling. Recently, the company received $34 million in grants, so expect this one to rebound very soon.
About Penny Stock Investor Relations Network
Throughout the market day, we provide you with all the penny stock news you need to make a profit on the market. We provide only the best, most reliable information to you.
Penny Stock Investor Relations Network is not a registered securities advisor. As always, conduct your own due diligence with any potential investment. The companies featured here provide their information through press releases, newsletters and company news, but that should not be seen as a sole reason or recommendation to buy or sell.
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)